In the 2022 edition of WHO, it was pointed out that FH somatic mutations may also lead to the development of this type of renal cell carcinoma, and have extremely similar biological behaviors to HLRCC caused by FH germline mutations. This evidence concerns the gene FH and hereditary clear cell renal cell carcinoma.